ENDV实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (7 May 2024 @ 00:00):

Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine...

Stats
今日成交量	80 110.00
平均成交量	1.28M
市值	696 473
EPS	$-0.0100 ( 2023-08-21 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0.220
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2020-07-01	Collier Alan Brian	Buy	100	Common Stock
2020-07-01	Collier Alan Brian	Buy	100	Common Stock
2020-06-30	Collier Alan Brian	Buy	200	Common Stock
2020-02-22	Collier Alan Brian	Buy	100	Common Stock
2020-01-02	Collier Alan Brian	Buy	100	Common Stock

INSIDER POWER
0.00
Last 100 transactions
Buy: 301 200 \| Sell: 0

Endonovo Therapeutics, 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Endonovo Therapeutics, 财务报表

Annual	2023
营收:	$140 242
毛利润:	$-514 510 (-366.87 %)
EPS:	$0.0251

FY	2023
营收:	$140 242
毛利润:	$-514 510 (-366.87 %)
EPS:	$0.0251

FY	2022
营收:	$135 355
毛利润:	$125 365 (92.62 %)
EPS:	$-0.230

FY	2021
营收:	$73 105.00
毛利润:	$58 120.00 (79.50 %)
EPS:	$-0.0500

Financial Reports:

No articles found.

Endonovo Therapeutics,

Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of inflammation, wounds, cardiovascular diseases, chronic kidney diseases, liver diseases, non-alcoholic steatohepatitis, peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.